See our recent news and announcements below. If you have any questions or for media inquiries, please contact firstname.lastname@example.org for assistance or see specified media contact details within each release.
WALTHAM, MA, Thursday, January 19, 2023 -
Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, has announced its participation this week in the B. Riley Securities 3rd Annual Oncology Conference. Its Chief Executive Officer, Dr. Brian Lestini, will present on Thursday, January 19, 2023, at 2 PM ET.